JPRN-UMIN000015708尚未招募未知
Efficacy and Safety of Yokukansan in Autism Spectrum disorder: A Randomized, Multi-center, Double-Blind, Placebo-Controlled Trial - Efficacy and safety of yokukansan in autism spectrum disorder
Shimane University School of Medicine0 个研究点目标入组 100 人开始时间: 2014年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6years-old 至 17years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Presence of any active medical condition, diagnosis of any other psychiatric disorder on the DSM-5, use of any psychotropic medication in the six weeks prior to the baseline visit and history of hepatic disease or seizure could exclude the subject from this study.
研究者
相似试验
招募中
2 期
Efficacy and safety of Yokukansan for the treatment-resistant schizophrenia: randomized, double-blind, placebo-controlled multicenter trialTreatment-Rsistant SchizophreniaJPRN-UMIN000005018Department of Psychiatry, Shimane University School of Medicine120
招募中
不适用
Efficacy and Safety of Yokukansan in Schizophrenia: A Randomized, Multi-center, Double-Blind, Placebo-Controlled TrialSchizophreniaJPRN-UMIN000015709Shimane University School of Medicine60
未知
不适用
The safety and efficacy of Yokukansan in treating neuropsychiatric symptoms of patients with Fronto-Temporal Lobar Degeneration (FTLD)Fronto-Temporal Lobar Degeneration (FTLD)JPRN-UMIN000001897Ehime University Graduate School of Medicine20
未知
不适用
Evaluation of efficacy of yokukansan in patients with dementia with Lewy bodies using NPI-D as an indicator.Dementia with Lewy bodiesJPRN-UMIN000001832Department of Geriatric Medicine, Kyorin University School of Medicine20
已完成
不适用
To investigate the efficacy and safety of Yokukansan for patients with insomniaPsychophysiological insomniaJPRN-UMIN000001412The Jikei university school of medicine10